Three-dimensional telomere profiles in papillary thyroid cancer variants: A pilot study.


Journal

Bosnian journal of basic medical sciences
ISSN: 1840-4812
Titre abrégé: Bosn J Basic Med Sci
Pays: Bosnia and Herzegovina
ID NLM: 101200947

Informations de publication

Date de publication:
01 Jun 2022
Historique:
received: 19 10 2021
accepted: 11 11 2021
pubmed: 10 12 2021
medline: 7 6 2022
entrez: 9 12 2021
Statut: epublish

Résumé

Besides the two main histologic types of papillary thyroid carcinoma (PTC), the classical PTC (CL-PTC) and the follicular variant PTC (FV-PTC), several other variants are described. The encapsulated FV-PTC variant was recently reclassified as noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) due to its similarities to benign lesions. Specific molecular signatures, however, are still unavailable. It is well known that improper DNA repair of dysfunctional telomeres may cause telomere-related genome instability. The mechanisms involved in the damaged telomere repair processing may lead to detrimental outcomes, altering the three-dimensional (3D) nuclear telomere and genome organization in cancer cells. This pilot study aimed to evaluate whether a specific 3D nuclear telomere architecture might characterize NIFTP, potentially distinguishing it from other PTC histologic variants. Our findings demonstrate that 3D telomere profiles of CL-PTC and FV-PTC were different from NIFTP and that NIFTP more closely resembles follicular thyroid adenoma (FTA). NIFTP has longer telomeres than CL-PTC and FV-PTC samples, and the telomere length of NIFTP overlaps with that of the FTA histotype. In contrast, there was no association between BRAF expression and telomere length in all tested samples. These preliminary findings reinforce the view that NIFTP is closer to non-malignant thyroid nodules and confirm that PTC features short telomeres.

Identifiants

pubmed: 34882527
doi: 10.17305/bjbms.2021.6639
pmc: PMC9162746
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

481-487

Références

Leukemia. 2009 Mar;23(3):565-73
pubmed: 19039323
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9613-8
pubmed: 15983382
Biology (Basel). 2021 Feb 05;10(2):
pubmed: 33562578
JAMA. 2006 May 10;295(18):2164-7
pubmed: 16684987
Hum Pathol. 2018 Dec;82:32-38
pubmed: 30146440
Transl Oncol. 2013 Dec 01;6(6):749-56
pubmed: 24466378
J Microsc. 2001 Nov;204(Pt 2):99-107
pubmed: 11737543
Genes Dev. 2008 Jan 15;22(2):125-40
pubmed: 18198332
Ann Diagn Pathol. 2020 Feb;44:151439
pubmed: 31865250
Endocr Relat Cancer. 2013 Jun 27;20(4):527-36
pubmed: 23722226
Clinics (Sao Paulo). 2018 May 21;73:e576
pubmed: 29791602
Cancer Genet Cytogenet. 2010 Nov;203(1):21-9
pubmed: 20951315
J Clin Endocrinol Metab. 2011 Nov;96(11):E1852-6
pubmed: 21865371
Science. 2009 Nov 13;326(5955):948-52
pubmed: 19965504
Int J Mol Sci. 2016 Oct 21;17(10):
pubmed: 27775641
Endocr Connect. 2020 Feb 1;:
pubmed: 32061158
Cell. 2014 Oct 23;159(3):676-90
pubmed: 25417114
Transl Oncol. 2016 Aug;9(4):348-56
pubmed: 27567959
Neurotox Res. 2017 Nov;32(4):563-574
pubmed: 28597409
Cancer. 2006 Sep 15;107(6):1255-64
pubmed: 16900519
JAMA Oncol. 2016 Aug 1;2(8):1023-9
pubmed: 27078145
Endocr Relat Cancer. 2018 Apr;25(4):R247-R258
pubmed: 29439059
J Cell Physiol. 2019 Apr;234(4):5175-5185
pubmed: 30328617
Am J Pathol. 2011 Sep;179(3):1415-24
pubmed: 21763260
Oncogene. 2007 Mar 1;26(10):1398-406
pubmed: 16953226
Cytometry A. 2005 Oct;67(2):144-50
pubmed: 16163697
Cells. 2019 Apr 02;8(4):
pubmed: 30987070
Cancers (Basel). 2018 Aug 24;10(9):
pubmed: 30149530

Auteurs

Aline Rangel-Pozzo (A)

Department of Cell Biology, Research Institute of Oncology and Hematology, CancerCare Manitoba, University of Manitoba, Winnipeg, Canada.

Tinuccia Dettori (T)

Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.

Daniela Virginia Frau (D)

Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.

Federica Etzi (F)

Department of Biomedical Sciences-Histology, University of Sassari, Viale San Pietro, Sassari, Italy.

John Gartner (J)

Department of Pathology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.

Garbor Fisher (G)

Department of Pathology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.

Roberta Vanni (R)

Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.

Sabine Mai (S)

Department of Cell Biology, Research Institute of Oncology and Hematology, CancerCare Manitoba, University of Manitoba, Winnipeg, Canada.

Paola Caria (P)

Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH